lyMbyc

Bengaluru, India Founded: 2012 • Age: 14 yrs Listed Acquired By L&T Infotech
Predictive analytics are delivered for pharma and consumer technology sectors.
Request Access
Report Incorrect Data
Page last updated

About lyMbyc

lyMbyc is a publicly listed company based in Bengaluru (India) founded in 2012 by Hemalatha Rajan and Satyakam Mohanty, and was acquired by L&T Infotech in July 2019. It operates as a predictive analytics are delivered for pharma and consumer technology sectors. It operates in the Technology, Industrial Goods & Manufacturing, and Healthcare sectors. The company has 66,188 employees. Its chief executive is Satyakam Mohanty. Its Indian entity Ltm Limited reported revenue of ₹43,402 Cr. lyMbyc offers products and services including Blog Articles, Eye Contacts Guide, and Gaming Strategies. Its focus areas include Enterprise Applications, Vertical Business Intelligence, Industry Specific and MarketingTech. Its competitors include data.ai, Definitive Healthcare, TapClicks, Urbint and SPINS and 5 more; 9 of its 10 listed competitors have raised funding.

Company details

Lymbyc was founded in 2012 in Bengaluru, India. Predictive analytical solutions are supplied to pharmaceutical and consumer technology industries. Customer journey insights are extracted by analyzing data from social media, CRM, ERP, feedback, and other sources. Drug lifecycle patterns are examined and visualized for pharma firms, with events forecasted via hypothesis testing. Recognition was received in Gartners 2017 Market Guide for data science and machine learning services.

  • Headquarters Bengaluru, India
  • Employees 66,188
  • Founders Hemalatha Rajan, Satyakam Mohanty
  • Stage Acquired
  • Sectors
    Technology
    Industrial Goods & Manufacturing Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website lymbyc.com
  • Social LinkedIn X Facebook
  • Acquired by L&T Infotech (Jul 2019)
  • Legal Name Ltm Limited
  • Date of Incorporation 23 Dec, 1996
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Technology → Business Analytics & Intelligence Tools
Technology → MarketingTech
Industrial Goods & Manufacturing → Manufacturing Tech Solutions
Healthcare → Clinical IT & Data Platforms
Technology → SME & Vertical Software
Key Metrics
  • Market Cap
    ₹1,26,506 Cr

    LTM · NSE

  • Share Price
    ₹4,298.00

    +0.78% today

  • Revenue
    ₹42,308 Cr

    FY 2025-26 · +11.3% YoY

  • EBITDA
    ₹7,027 Cr

    Margin 16.6%

  • Net Profit
    ₹5,404 Cr

    FY 2025-26 · +17.5% YoY

  • P/E (TTM)
    22.6x

    P/B 4.9x

  • ROE
    21.3%

    ROCE 26.8%

  • Debt / Equity
    0.10

    Interest cover 4.6x

  • Investors
    L&T Infotech
  • Employee Count
    66,188
  • Acquired by
    L&T Infotech

    (Jul 2019)

Products & Services of lyMbyc

lyMbyc offers a comprehensive portfolio of products and services, including Blog Articles, Eye Contacts Guide, and Gaming Strategies.

Blog Articles
Content Publishing

Informational posts on fashion and gaming topics

Eye Contacts Guide
Fashion Accessory

Advice for using colored lenses in cosplay and fashion

Gaming Strategies
Entertainment Service

Tips for video games like WoW gold farming

Investors in lyMbyc

lyMbyc has secured backing from 1 investor. Prominent investors backing the company include L&T Infotech.

All
InvestorDescriptionFounded YearDomainLocation
L&T Infotech
IT services and solutions are provided worldwide.
1997lntinfotech.comMumbai, India
Premium access

Investor details for lyMbyc

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Ltm Limited (lyMbyc)

Ltm Limited is the primary company behind lyMbyc. The boards of the 2 registered companies of lyMbyc currently have 13 directors; the longest-serving is Sekharipuram Narayanan Subrahmanyan, appointed in 2015. 46 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sekharipuram Narayanan Subrahmanyan
DIN 02255382
Director10 Jan 201511 yrs 9 moLtm Limited
Ramamurthi Shankar Raman
DIN 00019798
Director28 Oct 201510 yrs 11 moLtm Limited
Sanjeev Aga
DIN 00022065
Director09 Nov 20169 yrs 11 moLtm Limited
Nachiket Gopal Deshpande
DIN 08385028
Director29 Aug 20197 yrs 1 moLymbyc Solutions Private Limited
James Varghese Abraham
DIN 02559000
Director18 Jul 20215 yrs 3 moLtm Limited
Vinayak Chatterjee
DIN 00008933
Director01 Apr 20224 yrs 6 moLtm Limited
Apurva Purohit
DIN 00190097
Director14 Nov 20223 yrs 11 moLtm Limited
Chandrasekaran Ramakrishnan
DIN 00580842
Director14 Nov 20223 yrs 11 moLtm Limited
Bijou Kurien
DIN 01802995
Director14 Nov 20223 yrs 11 moLtm Limited
Vinit Ajit Teredesai
DIN 03293917
Director29 Dec 20223 yrs 9 moLymbyc Solutions Private Limited
Sanjukta Kulkarni
DIN 09843162
Director30 Dec 20223 yrs 9 moLymbyc Solutions Private Limited
Venugopal Lambu
DIN 08840898
Managing Director31 May 20251 yr 4 moLtm Limited
Vipul Chandra
DIN 06692474
Whole-time director23 Apr 20265 moLtm Limited

People of lyMbyc

2 people are tracked at lyMbyc (2 in leadership); the tracked headcount is 66,188.

NameRoleGroup
Hemalatha Rajan
Co-Founder & DirectorLeadership
Satyakam Mohanty
Founder & CEOLeadership
Premium access

Complete people profiles for lyMbyc

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of lyMbyc

lyMbyc is a publicly listed company on the NSE with ticker symbol LTM in India, operating in the IT - Software sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: LTM
  • Listed entityLtm Limited
  • Exchange sectorIT - Software

Financials of lyMbyc

Exchange-reported figures of Ltm Limited, the listed company behind lyMbyc (NSE: LTM).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹42,308 Cr
+11.3% YoY
EBITDA
₹7,027 Cr
+8.2% YoY
Profit After Tax
₹5,404 Cr
+17.5% YoY
Net Worth
₹24,025 Cr
+5.8% YoY
Total Assets
₹27,779 Cr
+11.2% YoY
Total Debt
₹2,310 Cr
+5.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue42,30838,00835,51733,18326,10912,37010,879
Revenue growth+11.3%+7.0%+7.0%+27.1%+111.1%+13.7%-
EBITDA7,0276,4956,3876,1085,2492,7252,029
EBITDA margin+16.6%+17.1%+18.0%+18.4%+20.1%+22.0%+18.7%
Profit before tax6,7916,2146,0495,7925,2942,5882,003
Net profit5,4044,5994,5824,4083,9481,9361,520
Net profit margin+12.8%+12.1%+12.9%+13.3%+15.1%+15.7%+14.0%
EPS (₹)169.53155.36154.80148.93133.39110.6387.36
Balance sheet
Total assets27,77924,97422,14418,35315,7378,2346,638
Net worth24,02522,69820,01716,59214,2877,3035,404
Total debt2,3102,1872,071354258798912
Cash & bank2,8123,5882,8162,9321,837759525
Net working capital6,2927,9406,6937,3154,7072,0321,934
Cash flow
Cash from operations4,7994,5465,6703,0953,2512,4001,644
Cash from investing(1,604)(1,729)(3,918)(271)(1,643)(1,657)(643)
Cash from financing(2,926)(2,574)(2,269)(1,932)(1,680)(509)(890)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11,80811,60811,29210,78110,3949,8419,7729,661
Revenue growth (YoY)+13.6%+18.0%+15.6%+11.6%+10.2%+7.6%--
Other income91.50255237227300392251212
EBITDA2,0932,0611,9731,4121,9301,6491,5961,593
EBITDA margin+17.7%+17.8%+17.5%+13.1%+18.6%+16.8%+16.3%+16.5%
Depreciation255261264266282243251264
Interest69.9076.3065.3069.3069.3072.4067.3068.90
Profit before tax1,8601,9781,8811,3051,8791,7261,5291,472
Tax480510494345498472401386
Net profit1,3801,4691,3879601,3811,2551,1291,087
EPS (₹)47.1149.4246.9332.7147.2342.2838.0436.59
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue40,48236,68234,25331,97624,84511,56310,184
Revenue growth+10.4%+7.1%+7.1%+28.7%+114.9%+13.5%-
EBITDA6,7006,1706,1375,8704,9672,5051,866
EBITDA margin+16.6%+16.8%+17.9%+18.4%+20.0%+21.7%+18.3%
Profit before tax6,6395,9695,8795,5795,2072,3912,007
Net profit5,3234,4464,4864,2483,9121,6721,454
Net profit margin+13.2%+12.1%+13.1%+13.3%+15.8%+14.5%+14.3%
EPS (₹)166.68150.22151.55143.52132.17102.1489.22
Balance sheet
Total assets26,31524,00421,27817,33015,0247,6666,232
Net worth22,86821,83419,29815,97713,8756,9405,229
Total debt2,0852,0941,9320.000.000.000.00
Cash & bank2,0712,9652,5912,6561,718401371
Net working capital5,3767,3346,2486,6804,2211,6241,683
Cash flow
Cash from operations4,6334,0405,5302,8863,2062,1801,644
Cash from investing(1,524)(1,674)(3,834)(186)(1,352)(1,637)(570)
Cash from financing(2,952)(2,515)(2,163)(1,980)(1,682)(513)(918)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11,27610,98810,78210,3129,9679,4219,4239,286
Revenue growth (YoY)+13.1%+16.6%+14.4%+11.1%+9.5%+6.2%--
Other income94.7050.90240234288479227217
Total expenses9,2669,0458,9268,9828,0867,8517,9047,795
EBITDA2,0101,9431,8561,3301,8811,5701,5191,492
EBITDA margin+17.8%+17.7%+17.2%+12.9%+18.9%+16.7%+16.1%+16.1%
Depreciation233240249249249226229242
Interest67.4073.4063.3066.4065.4070.8065.8067.10
Profit before tax1,8041,6811,7841,2491,8541,7521,4521,399
Tax453440462320468455373357

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 21 Oct 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11,80811,60811,29210,78110,3949,8419,7729,661
Revenue growth (YoY)+13.6%+18.0%+15.6%+11.6%+10.2%+7.6%--
Other income91.50255237227300392251212
EBITDA2,0932,0611,9731,4121,9301,6491,5961,593
EBITDA margin+17.7%+17.8%+17.5%+13.1%+18.6%+16.8%+16.3%+16.5%
Depreciation255261264266282243251264
Interest69.9076.3065.3069.3069.3072.4067.3068.90
Profit before tax1,8601,9781,8811,3051,8791,7261,5291,472
Tax480510494345498472401386
Net profit1,3801,4691,3879601,3811,2551,1291,087
EPS (₹)47.1149.4246.9332.7147.2342.2838.0436.59
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue42,30838,00835,51733,18326,10912,37010,879
Revenue growth+11.3%+7.0%+7.0%+27.1%+111.1%+13.7%-
Other income1,094990702557766274329
Total expenses35,28031,51329,13027,07520,8609,6458,849
Employee cost26,28724,62322,73220,88015,9897,4296,517
EBITDA7,0276,4956,3876,1085,2492,7252,029
EBITDA margin+16.6%+17.1%+18.0%+18.4%+20.1%+22.0%+18.7%
Depreciation1,054992819723597332273
Interest27627922215012378.8082.60
Profit before tax6,7916,2146,0495,7925,2942,5882,003
Tax1,8081,6121,4641,3811,344650482
Net profit5,4044,5994,5824,4083,9481,9361,520
Net profit margin+12.8%+12.1%+12.9%+13.3%+15.1%+15.7%+14.0%
EPS (₹)169.53155.36154.80148.93133.39110.6387.36
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital29.6029.6029.6029.6029.6017.5017.40
Reserves & surplus23,99522,66919,98816,56214,2587,2865,387
Shareholders' funds (net worth)24,02522,69820,01716,59214,2877,3035,404
Minority interest82.7013.209.207.105.703.701.10
Secured loans0.002.3040.7012551.900.000.00
Unsecured loans2,3102,1852,030229206798912
Total debt2,3102,1872,071354258798912
Total liabilities27,77924,97422,14418,35315,7378,2346,638
Assets
Gross block9,9369,0698,5726,8906,2793,2843,110
Net block5,6265,2854,9813,6793,4731,9061,920
Capital work in progress92268155190250366.2059.20
Investments12,5689,8458,7445,4586,0483,7302,219
Inventories3.302.803.003.304.100.000.00
Sundry debtors7,4255,8685,7065,6234,5572,0842,312
Cash & bank balances2,8123,5882,8162,9321,837759525
Loans & advances5,4214,1053,5683,8853,1431,6601,273
Total current assets15,66213,56412,09312,4449,5424,5034,110
Total current liabilities9,3705,6245,4005,1294,8352,4722,176
Net working capital6,2927,9406,6937,3154,7072,0321,934
Total assets27,77924,97422,14418,35315,7378,2346,638
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash2,0621,8202,3381,4461,519525415
Net cash from operating activities4,7994,5465,6703,0953,2512,4001,644
Net cash from investing activities(1,604)(1,729)(3,918)(271)(1,643)(1,657)(643)
Net cash from financing activities(2,926)(2,574)(2,269)(1,932)(1,680)(509)(890)
Net change in cash269242(518)892(72.90)234110
Closing cash2,8123,5882,8162,9321,837759525
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+11.3%+7.0%+7.0%+27.1%+111.1%+13.7%-
EBITDA growth+8.2%+1.7%+4.6%+16.4%+92.6%+34.3%-
PBT growth+9.3%+2.7%+4.4%+9.4%+104.5%+29.2%-1.2%
Net income growth+17.5%+0.4%+3.9%+11.7%+103.9%+27.4%-
Revenue CAGR (3Y)+8.4%+13.3%+42.1%+45.0%+40.3%+19.2%+18.7%
EBITDA CAGR (3Y)+4.8%+7.4%+32.8%+44.4%+40.7%+31.9%+18.2%
Profitability & leverage
Net income margin+11.8%+12.1%+12.9%+13.3%+15.1%+15.7%+14.0%
Return on capital employed+26.8%+27.6%+31.0%+34.9%+45.2%+35.9%+35.8%
Return on net worth+21.3%+21.6%+25.1%+28.6%+36.6%+30.5%+29.5%
Debt / equity0.100.100.100.020.050.130.09
Long-term debt / equity0.080.080.080.000.030.110.07
Interest cover4.635.073.982.792.653.294.70
Efficiency & per share
Fixed asset turnover4.454.314.595.045.463.874.40
Inventory turnover13,871.3413,106.2411,275.248,968.3812,735.950.000.00
Debtors turnover6.376.576.276.527.865.635.26
EPS (₹)169.53155.36154.80148.93133.39110.6387.36
Dividend per share (₹)75.0065.0065.0060.0055.0040.0028.00
Book value per share (₹)811.66766.83676.25560.54482.68417.34310.57
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11,27610,98810,78210,3129,9679,4219,4239,286
Revenue growth (YoY)+13.1%+16.6%+14.4%+11.1%+9.5%+6.2%--
Other income94.7050.90240234288479227217
Total expenses9,2669,0458,9268,9828,0867,8517,9047,795
EBITDA2,0101,9431,8561,3301,8811,5701,5191,492
EBITDA margin+17.8%+17.7%+17.2%+12.9%+18.9%+16.7%+16.1%+16.1%
Depreciation233240249249249226229242
Interest67.4073.4063.3066.4065.4070.8065.8067.10
Profit before tax1,8041,6811,7841,2491,8541,7521,4521,399
Tax453440462320468455373357
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue40,48236,68234,25331,97624,84511,56310,184
Revenue growth+10.4%+7.1%+7.1%+28.7%+114.9%+13.5%-
Other income1,179974710502889225422
Total expenses33,78230,51328,11626,10619,8789,0588,318
Employee cost23,88122,59621,04919,42714,8846,8045,983
EBITDA6,7006,1706,1375,8704,9672,5051,866
EBITDA margin+16.6%+16.8%+17.9%+18.4%+20.0%+21.7%+18.3%
Depreciation973904760649530267208
Interest26627120714411971.6072.00
Profit before tax6,6395,9695,8795,5795,2072,3912,007
Tax1,7061,5221,3941,3301,295604455
Net profit5,3234,4464,4864,2483,9121,6721,454
Net profit margin+13.2%+12.1%+13.1%+13.3%+15.8%+14.5%+14.3%
EPS (₹)166.68150.22151.55143.52132.17102.1489.22
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital29.6029.6029.6029.6029.6017.5017.40
Reserves & surplus22,83921,80419,26915,94713,8466,9225,211
Shareholders' funds (net worth)22,86821,83419,29815,97713,8756,9405,229
Secured loans0.000.000.000.000.000.000.00
Unsecured loans2,0852,0941,9320.000.000.000.00
Total debt2,0852,0941,9320.000.000.000.00
Total liabilities26,31524,00421,27817,33015,0247,6666,232
Assets
Gross block7,8437,5097,0115,3994,6691,7041,708
Net block4,5224,5614,2202,9312,5501,0301,152
Capital work in progress89456347785647243.0040.00
Investments13,18010,3579,2035,9196,7114,3902,874
Inventories3.302.803.003.304.100.000.00
Sundry debtors7,1225,6725,3725,3184,3282,0212,177
Cash & bank balances2,0712,9652,5912,6561,718401371
Loans & advances5,0573,9083,4623,8072,9631,5241,220
Total current assets14,25312,54711,42811,7859,0133,9463,768
Total current liabilities8,8775,2135,1805,1054,7922,3222,085
Net working capital5,3767,3346,2486,6804,2211,6241,683
Total assets26,31524,00421,27817,33015,0247,6666,232
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1,4451,5952,0621,3421,160371215
Net cash from operating activities4,6334,0405,5302,8863,2062,1801,644
Net cash from investing activities(1,524)(1,674)(3,834)(186)(1,352)(1,637)(570)
Net cash from financing activities(2,952)(2,515)(2,163)(1,980)(1,682)(513)(918)
Net change in cash157(150)(467)72017329.70156
Closing cash2,0712,9652,5912,6561,718401371
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+10.4%+7.1%+7.1%+28.7%+114.9%+13.5%-
EBITDA growth+8.6%+0.5%+4.6%+18.2%+98.3%+34.3%-
PBT growth+11.2%+1.5%+5.4%+7.1%+117.8%+19.1%+2.4%
Net income growth+19.7%-0.9%+5.6%+8.6%+134.0%+15.0%-
Revenue CAGR (3Y)+8.2%+13.9%+43.6%+46.4%+40.8%+18.7%+18.1%
EBITDA CAGR (3Y)+4.5%+7.5%+34.8%+46.5%+42.3%+33.7%+19.3%
Profitability & leverage
Net income margin+12.2%+12.1%+13.1%+13.3%+15.8%+15.5%+15.2%
Return on capital employed+27.5%+27.6%+31.5%+35.4%+46.9%+35.4%+37.9%
Return on net worth+22.1%+21.6%+25.4%+28.5%+37.6%+29.4%+31.2%
Debt / equity0.090.100.050.000.000.000.00
Long-term debt / equity0.080.080.050.000.000.000.00
Interest cover4.645.143.852.762.683.204.34
Efficiency & per share
Fixed asset turnover5.275.055.526.357.806.788.19
Inventory turnover13,272.8512,649.1410,874.108,642.0312,119.710.000.00
Debtors turnover6.336.646.416.637.835.515.21
EPS (₹)166.68150.22151.55143.52132.17102.1489.22
Dividend per share (₹)75.0065.0065.0060.0055.0040.0028.00
Book value per share (₹)772.58737.64651.97539.76468.75396.56300.51

Timeline of lyMbyc

2 dated milestones of lyMbyc across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded lyMbyc is founded.
  2. Exit Acquired by L&T Infotech.

Competitors of lyMbyc

lyMbyc has 10 listed competitors in our database, 9 of them funded. They include data.ai, Definitive Healthcare, TapClicks, Urbint and SPINS, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
data.ai
data.ai2010San Francisco, United States$157M123
Market data is analyzed by AI to generate consumer insights.
Definitive Healthcare
definitivehc.com2008Natick, United States$4.31M575
Offers market intelligence and data analytics for healthcare providers and physicians
TapClicks
tapclicks.com2011San Jose, United States$23.5M64
Cloud based marketing management platform for businesses
Urbint
urbint.com2015New York, United States$130.08M–
AI-driven urban datasets and analysis tools are offered by Urbint.
SPINS
spins.com1995Chicago, United States–328
Retail consumer analytics services are provided for natural products sector.
4C Insights
4cinsights.com2011Chicago, United States$31.7M282
Cloud-based market intelligence is delivered across closed ecosystems.
Funnel
funnel.io2014Stockholm, Sweden$131M–
Cloud-based platform for integrating and analyzing marketing data is offered.
InMarket
inmarket.com2010Austin, United States$1M264
Marketing measurement solutions are delivered to link brands with consumers.
EDO
edo.com2014Los Angeles, United States$92.44M101
EDO is recognized as a TV outcomes company focused on advertising analytics.
AMPLYFI
amplyfi.com2015Cardiff, United Kingdom$11.85M40
Open-source data is curated, analyzed, and visualized via AI platform.
Premium access

Detailed competitors of lyMbyc

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Business Analytics & Intelligence Tools

10 companies that operate in the same segment as lyMbyc (Business Analytics & Intelligence Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Databricks
Data, analytics, and AI capabilities are unified in a platform.
2013San Francisco, California, United StatesUSD 25.18 BUSD 15.9 M5,679
Palantir
Platform that provides data analysis and management solutions
2003Denver, Colorado, United StatesUSD 2.46 BUSD 2.87 B5,915
Affle
Consumer intelligence-driven mobile marketing platform is provided for user acquisition.
2005Singapore, SingaporeUSD 10 MUSD 288.73 M618
Verily
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B–1,111
Fractal Analytics
Artificial intelligence and analytics solutions are provided for enterprise transformation.
2000New York, New York, United StatesUSD 685 MUSD 270.83 M5,217
Confluent
Cloud based data streaming analytics and governance platform
2014Mountain View, California, United StatesUSD 456 MUSD 963.64 M3,583
Drata
Risk assessment and management solutions are provided for enterprises.
2020San Diego, California, United StatesUSD 328.24 M–2,114
Trax
Cloud-based analytics solutions for retail shelf management are delivered.
2010Singapore, Singapore, SingaporeUSD 1.03 BUSD 15.24 M567
Primer
AI based text summarization and contextualization software tool
2015San Francisco, California, United StatesUSD 222.7 M–194
Riskified
AI-based fraud prevention for e-commerce payments is provided.
2013New York, New York, United StatesUSD 232.02 MUSD 346.08 M724
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lymbyc

LTM: Introduces BlueVerse™ ValueMesh™ To Assist Businesses In Expanding AI During Oracle Transformations.
Exchange Update • today
LTM Expects Shorter AI Deals To Accelerate Revenue Growth In H2 FY27
Exchange Update • 2 days ago
LTM: Q2 REVENUE 118B RUPEES VS 116B (QOQ)
Exchange Update • 5 days ago
LTM: Q2 CONS NET PROFIT 13.98B RUPEES VS 14.66B (QOQ); EST 15B
Exchange Update • 5 days ago
LTM: Q2 EBIT 18.4B RUPEES VS 18B (QOQ); Q2 EBIT MARGIN 15.57% VS 15.5% (QOQ)
Exchange Update • 5 days ago
LTIMINDTREE: CO DECLARES INTERIM DIVIDEND OF 25 RUPEES PER EQUITY SHARE
Exchange Update • 5 days ago
LTM: Company Lands Big Managed Services Deal For AI-Driven Transformation
Exchange Update • 6 days ago
LTM: Board Meeting Scheduled For October 16 To Review Q2 Results And Discuss Interim Dividend, Record Date Set For October 23.
Exchange Update • 13 days ago
LTM: Partners With Google Cloud To Boost Gemini Enterprise Adoption.
Exchange Update • 14 days ago
LTM: Introduces Blueverse™ AgentTraceIQ For Safe Use Of Agentic AI; Teams Up With Rubrik For Combined AI Oversight And Services
Exchange Update • 16 days ago
Premium access

Complete news archive for lyMbyc

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about lyMbyc

lyMbyc was founded in 2012.

lyMbyc is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Satyakam Mohanty is the current CEO of lyMbyc. They have also founded this company.

lyMbyc has 66,188 employees.

The primary company behind lyMbyc, Ltm Limited, reported revenue of ₹43,402 Cr for FY 2026, up 11% year on year.

Lymbyc was founded in 2012 in Bengaluru, India. Predictive analytical solutions are supplied to pharmaceutical and consumer technology industries. Customer journey insights are extracted by analyzing data from social media, CRM, ERP, feedback, and other sources. Drug lifecycle patterns are examined and visualized for pharma firms, with events forecasted via hypothesis testing. Recognition was received in Gartners 2017 Market Guide for data science and machine learning services.

lyMbyc's top competitors include 4C Insights, EDO and TapClicks.

lyMbyc offers Blog Articles, Eye Contacts Guide, and Gaming Strategies.

Yes, lyMbyc is publicly traded on NSE under the ticker symbol LTM.

lyMbyc has 1 investor. Key investors include L&T Infotech.

lyMbyc is associated with 2 legal entities: Ltm Limited, Lymbyc Solutions Private Limited.

Yes. lyMbyc was acquired by L&T Infotech in July 2019.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available